AGM/EGMApr 27, 2026, 04:02 PM
VOR Annual Meeting June 11, 2026; Director Elections, Equity Plan Vote
AI Summary
Vor Biopharma Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026. Stockholders will vote on the election of two Class II director nominees, the amendment and restatement of the 2021 Equity Incentive Plan, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date for voting is April 15, 2026, with proxy materials available online from April 27, 2026.
Key Highlights
- Annual Meeting to be held virtually on June 11, 2026, at 9:00 a.m. Eastern Time.
- Stockholders to elect two Class II director nominees for a three-year term.
- Proposal to approve the amendment and restatement of the 2021 Equity Incentive Plan.
- Proposal to ratify Ernst & Young LLP as independent auditor for fiscal year 2026.
- Record date for stockholders entitled to vote is April 15, 2026.
- Proxy materials were made available to stockholders on or about April 27, 2026.
Price Impact
More from VOR